Literature DB >> 29668499

Tumor Syndromes Predisposing to Osteosarcoma.

Meera Hameed1, Diana Mandelker.   

Abstract

Osteosarcoma (OS) is the most common primary bone tumor affecting predominantly adolescents and young adults. It accounts for about 5% of all childhood cancers. Although the majority of OSs are sporadic, a small percentage occur as a component of hereditary cancer syndromes. Early onset, bilateral, multifocal, and metachronous tumors suggest genetic predisposition. The inheritance patterns can be autosomal dominant or recessive. These syndromes predispose to a wide variety of mesenchymal and epithelial cancers with propensity for certain mutations being prevalent in specific cancer subtypes. Li-Fraumeni syndrome, retinoblastoma, Rothmund-Thompson syndrome (type 2), Werner syndrome, and Bloom syndrome, constitute the majority of the tumor syndromes predisposing to OS and will be the focus for this review.

Entities:  

Mesh:

Year:  2018        PMID: 29668499      PMCID: PMC6688172          DOI: 10.1097/PAP.0000000000000190

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  24 in total

Review 1.  Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications.

Authors:  Tianyi Zhu; Jing Han; Liu Yang; Zhengdong Cai; Wei Sun; Yingqi Hua; Jing Xu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

2.  Osteosarcoma in One of Identical Twins: Three Cases Report and a Literature Review.

Authors:  Jie Zhao; Wei Wang; Zhiyong Liu; Xiao Li; Qiqing Cai; Xiuchun Yu
Journal:  Orthop Surg       Date:  2021-05-05       Impact factor: 2.071

3.  International trends in incidence of osteosarcoma (1988-2012).

Authors:  Gabriela A Rojas; Aubrey K Hubbard; Brandon J Diessner; Karina B Ribeiro; Logan G Spector
Journal:  Int J Cancer       Date:  2021-05-17       Impact factor: 7.316

4.  Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p.

Authors:  Hongtao He; Muliang Ding; Tao Li; Wenzhi Zhao; Lu Zhang; Peng Yin; Wei Zhang
Journal:  Lab Invest       Date:  2022-03-24       Impact factor: 5.502

Review 5.  Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact.

Authors:  Claudia Maria Hattinger; Maria Pia Patrizio; Silvia Luppi; Massimo Serra
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 6.  Protective Mechanisms Against DNA Replication Stress in the Nervous System.

Authors:  Clara Forrer Charlier; Rodrigo A P Martins
Journal:  Genes (Basel)       Date:  2020-06-30       Impact factor: 4.096

Review 7.  Efficacy of methotrexate, doxorubicin, and cisplatin for osteosarcoma: Study protocol for a systematic review of randomized controlled trial.

Authors:  Qing-Xi Tang; Lu-Chuan Wang; Yu Wang; Hong-da Gao; Zhi-Ling Hou
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 8.  Anti-cancer properties of quercetin in osteosarcoma.

Authors:  Parisa Maleki Dana; Fatemeh Sadoughi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2021-07-05       Impact factor: 5.722

9.  Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment.

Authors:  Tao Zhang; Yingli Nie; Haifa Xia; Yanbin Zhang; Kailin Cai; Xiangdong Chen; Huili Li; Jiliang Wang
Journal:  Front Oncol       Date:  2020-07-24       Impact factor: 6.244

10.  Neuromuscular electrical stimulation for cancer pain in children with osteosarcoma: A protocol of systematic review.

Authors:  Tian-Shu Wang; Shou-Feng Wang; Wei-Dong Song; Zhao-Chen Tang; Wei Wei; Guan-Kai Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.